The SPOrt Project: Cosmological and Astrophysical Goals

We present the cosmological and astrophysical objectives of the SPOrt mission, which is scheduled for flying on the International Space Station (ISS) in the year 2002 with the purpose of measuring the diffuse sky polarized radiation in the microwave region. We discuss the problem of disentangling the cosmic background polarized signal from the Galactic foregrounds.Comment: 10 pages; 5 PS figures; requires aipproc2.cls, aipproc2.sty, epsfc.tex; to appear in Proc. of ``3K Cosmology'', Rome 5-10 Oct. 199

Recent results from the Arctic Radiation and Turbulence Interaction STudy (ARTIST) project

Ground-based measurements were conducted at Ny-˚Alesund in the Svalbard Islands in the framework of the research project ARTIST (Arctic Radiation and Turbulence Interaction STudy) funded by the European Communities. Key objectivesof the campaign were: 1) provide all participantswith ground reference data as input to models describing the development of the atmospheric boundary level, 2) compute the surface roughness length in order to characterise the surface of the site, 3) parameterise the surface energy exchanges, calculating the surface radiation flux, the sensible and latent heat fluxes, and 4) obtain the surface energy balance during both clear and cloudy sky conditions. The cloud radiative forcing has been also estimated. Final results of the analysis of the data set are presented

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes

Introduction: Although patient-reported outcome (PRO) measures provide important information beyond clinical data, studies that assess the PROs of type 2 diabetes mellitus (T2DM) patients initiating injectable glucose-lowering medications in routine clinical practice are limited. We describe the perspectives of patients based on a diversified panel of generic and disease-specific PRO measures at the time of enrollment (baseline) in the TROPHIES study. Methods: TROPHIES is a 24-month prospective observational study performed in France, Germany, and Italy in patients with T2DM who initiated their first injectable glucose-lowering medication with once-weekly dulaglutide or once-daily liraglutide. To better understand the perspectives of these patients regarding their overall health, treatment satisfaction, and quality of life and work, the patients’ responses to the following questionnaires were collected at baseline before they initiated treatment with dulaglutide or liraglutide: EQ-5D-5L (scale: 0–1), EQ-VAS (visual analog scale: 0–100), Impact of Weight on Self-Perceptions Questionnaire (IW-SP; scale: 0–100), Diabetes Treatment Satisfaction Questionnaire Status (DTSQs; scale: 0–36), and Diabetes Productivity Measure (DPM; scale: 0–100). Analyses were descriptive in nature, with higher scores reflecting better outcomes. Results: Data from patients at the time of enrollment were analyzed. At baseline, patients initiating dulaglutide (N = 1130) or liraglutide (N = 1051) rated their quality of life in terms of mean EQ-5D-5L index as 0.84 and 0.83, and in terms of mean EQ-VAS as 67.5 and 67.5, respectively. The mean baseline scores in patients initiating dulaglutide or liraglutide were 59.8 and 61.3 for IW-SP, 24.6 and 25.8 for DTSQs, 78.6 and 79.5 for DPM Life Productivity, and 87.5 and 86.8 for DPM Work Productivity, respectively. Conclusion: The information from this varied panel of PRO instruments collected at baseline complements clinical outcomes data

Connectivity-based parcellation of the thalamus explains specific cognitive and behavioural symptoms in patients with bilateral thalamic infarct

A novel approach based on diffusion tractography was used here to characterise the cortico-thalamic connectivity in two patients, both presenting with an isolated bilateral infarct in the thalamus, but exhibiting partially different cognitive and behavioural profiles. Both patients (G.P. and R.F.) had a pervasive deficit in episodic memory, but only one of them (R.F.) suffered also from a dysexecutive syndrome. Both patients had an MRI scan at 3T, including a T1-weighted volume. Their lesions were manually segmented. T1-volumes were normalised to standard space, and the same transformations were applied to the lesion masks. Nineteen healthy controls underwent a diffusion-tensor imaging (DTI) scan. Their DTI data were normalised to standard space and averaged. An atlas of Brodmann areas was used to parcellate the prefrontal cortex. Probabilistic tractography was used to assess the probability of connection between each voxel of the thalamus and a set of prefrontal areas. The resulting map of corticothalamic connections was superimposed onto the patients' lesion masks, to assess whether the location of the thalamic lesions in R.F. (but not in G. P.) implied connections with prefrontal areas involved in dysexecutive syndromes. In G.P., the lesion fell within areas of the thalamus poorly connected with prefrontal areas, showing only a modest probability of connection with the anterior cingulate cortex (ACC). Conversely, R.F.'s lesion fell within thalamic areas extensively connected with the ACC bilaterally, with the right dorsolateral prefrontal cortex, and with the left supplementary motor area. Despite a similar, bilateral involvement of the thalamus, the use of connectivity-based segmentation clarified that R.F.'s lesions only were located within nuclei highly connected with the prefrontal cortical areas, thus explaining the patient's frontal syndrome. This study confirms that DTI tractography is a useful tool to examine in vivo the effect of focal lesions on interconnectivity brain patterns

The Sport Project: an Experimental Overview

The Sky Polarization Observatory (SPOrt) is presented as a project aimed to measure the diffuse sky polarized emission, from the International Space Station, in the frequency range 20-90 GHz with 7 degrees of HPBW. The SPOrt experimental configuration is described with emphasis on the aspects that make SPOrt the first European scientific payload operating at microwave wavelengths

Commissioning of the CMS High Level Trigger

The CMS experiment will collect data from the proton-proton collisions delivered by the Large Hadron Collider (LHC) at a centre-of-mass energy up to 14 TeV. The CMS trigger system is designed to cope with unprecedented luminosities and LHC bunch-crossing rates up to 40 MHz. The unique CMS trigger architecture only employs two trigger levels. The Level-1 trigger is implemented using custom electronics, while the High Level Trigger (HLT) is based on software algorithms running on a large cluster of commercial processors, the Event Filter Farm. We present the major functionalities of the CMS High Level Trigger system as of the starting of LHC beams operations in September 2008. The validation of the HLT system in the online environment with Monte Carlo simulated data and its commissioning during cosmic rays data taking campaigns are discussed in detail. We conclude with the description of the HLT operations with the first circulating LHC beams before the incident occurred the 19th September 2008

Use of and association between heart failure pharmacological treatments and outcomes in obese versus non-obese patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry.

AIMS: To investigate the use of guideline-directed medical therapies (GDMT) and associated outcomes in obese (body mass index ≥30 kg/m2 ) versus non-obese patients with heart failure (HF) with reduced ejection fraction (HFrEF). METHODS AND RESULTS: Patients with HFrEF from the Swedish HF Registry were included. Of 16 116 patients, 24% were obese. In obese versus non-obese patients, use of treatments was 91% versus 86% for renin-angiotensin system inhibitors (RASi)/angiotensin receptor-neprilysin inhibitors (ARNi), 94% versus 91% for beta-blockers, 53% versus 43% for mineralocorticoid receptor antagonists. Obesity was shown to be independently associated with more likely use of each treatment, triple combination therapy, and the achievement of target dose by multivariable logistic regressions. Multivariable Cox regressions showed use of RASi/ARNi and beta-blockers being independently associated with lower risk of all-cause/cardiovascular death regardless of obesity, although, when considering competing risks, a lower risk of cardiovascular death with RASi/ARNi in obese versus non-obese patients was observed. RASi/ARNi were associated with lower risk of HF hospitalization in obese but not in non-obese patients, whereas beta-blockers were not associated with the risk of HF hospitalization regardless of obesity. At the competing risk analysis, RASi/ARNi use was associated with higher risk of HF hospitalization regardless of obesity. CONCLUSION: Obese patients were more likely to receive optimal treatments after adjustment for factors affecting tolerability, suggesting that perceived beyond actual tolerance issues limit GDMT implementation. RASi/ARNi and beta-blockers were associated with lower mortality regardless of obesity, with a greater association between RASi/ARNi and lower cardiovascular death in obese versus non-obese patients when considering competing risk

Burden of hip fracture using disability-adjusted life-years: a pooled analysis of prospective cohorts in the CHANCES consortium

Background No studies have estimated disability-adjusted life-years (DALYs) lost due to hip fractures using real-life follow-up cohort data. We aimed to quantify the burden of disease due to incident hip fracture using DALYs in prospective cohorts in the CHANCES consortium, and to calculate population attributable fractions based on DALYs for specific risk factors. Methods We used data from six cohorts of participants aged 50 years or older at recruitment to calculate DALYs. We applied disability weights proposed by the National Osteoporosis Foundation and did a series of sensitivity analyses to examine the robustness of DALY estimates. We calculated population attributable fractions for smoking, body-mass index (BMI), physical activity, alcohol intake, type 2 diabetes and parity, use of hormone replacement therapy, and oral contraceptives in women. We calculated summary risk estimates across cohorts with pooled analysis and randomeffects meta-analysis methods. Findings 223 880 men and women were followed up for a mean of 13 years (SD 6). 7724 (3·5%) participants developed an incident hip fracture, of whom 413 (5·3%) died as a result. 5964 DALYs (27 per 1000 individuals) were lost due to hip fractures, 1230 (20·6%) of which were in the group aged 75–79 years. 4150 (69·6%) DALYs were attributed to disability. Current smoking was the risk factor responsible for the greatest hip fracture burden (7·5%, 95% CI 5·2–9·7) followed by physical inactivity (5·5%, 2·1–8·5), history of diabetes (2·8%, 2·1–4·0), and low to average BMI (2·0%, 1·4–2·7), whereas low alcohol consumption (0·01–2·5 g per day) and high BMI had a protective effect. Interpretation Hip fracture can lead to a substantial loss of healthy life-years in elderly people. National public health policies should be strengthened to reduce hip fracture incidence and mortality. Primary prevention measures should be strengthened to prevent falls, and reduce smoking and a sedentary lifestyle

La stampa 3D in ortopedia: indicazioni e limiti [3D printing products in orthopedics: indications and limits]

Introduzione. Negli ultimi decenni, lo sviluppo delle tecniche e dei materiali ha permesso profondi passi avanti in diversi campi della tecnologia; la medicina, e in particolare l’ortopedia, è tra i settori che ne hanno maggiormente giovato. Sebbene la tecnologia di stampa 3D sia disponibile da diversi decenni, le elevate spese di gestione e i risultati insufficienti ne avevano ridotto l’applicazione solo in campo industriale e meccanico; negli ultimi anni, grazie anche alla riduzione dei prezzi, si è verificata una netta diffusione della stampa 3D anche in campo medico e in particolar modo ortopedico. La stampa tridimensionale permette il passaggio da un modello tridimensionale computerizzato a un manufatto reale, “stampato” da apposite stampanti 3D. Tale processo si basa sulla sovrapposizione progressiva di strati di spessore e materiali variabili, quali polimeri plastici o metalli, secondo uno schema preciso e computerizzato, che viene detto “additivo” per contrapposizione alle tecniche di produzione tradizionali che prevedono la sottrazione di materiale in eccesso da un volume di partenza per la produzione del manufatto definitivo. Materiali e metodi. Sono stati valutati i principali campi di applicazione della stampa 3D in ortopedia, analizzando il processo che porta all’impianto di una protesi custom-made in titanio, stampata con tecnologia 3D. Risultati. Possiamo identificare sette principali usi in ortopedia: uso didattico, planning operatorio, informazione del paziente, produzione di protesi custom-made, produzione di strumenti chirurgici anche dedicati al singolo paziente, template per spaziatori in cemento antibiotato, produzione di ortesi esterne e tutori personalizzati. La corretta interazione tra ortopedico e ingegnere è alla base della riuscita del prodotto custom-made; una volta raggiunto un accordo, saranno necessari circa 30 giorni per avere il prodotto impiantabile. Conclusioni. La tecnologia di stampa 3D è da considerarsi oggi una valida arma nelle mani dell’ortopedico per la risoluzione di casi difficili. I limiti più importanti sono oggi costituiti dal rischio di infezione e dall’osteointegrazione. Altri sviluppi e indicazioni probabilmente si avranno parallelamente all’ulteriore sviluppo tecnologico.Introduction. In recent decades, technical developments have brought an evident progress in several scientific areas; medicine, and in particular orthopedics, is probably one of the sectors which has most benefited from them. In fact, although 3D-printing technology has been available for several years, the high costs and the insufficient results reduced its application only to the industrial and mechanical field; in recent times, thanks to progress of technique and materials, 3D-printing is obtaining more importance in medicine also, and particularly in orthopedics. 3D-printing allows the transition from a computerized three-dimensional model to a real artifact, “printed” by special 3D-printers. This process is based on the gradual superposition of layers of variable materials, such as plastic polymers or metals, according to a precise computerized pattern. Materials and methods. The main orthopedic applications of 3D printing were evaluated, analyzing the process that leads to the production of a custom-made titanium prosthesis, printed with 3D technology. Results. We identified seven main uses in orthopedics: educational use, operative planning, patient education, production of custom-made prosthesis, production of surgical instruments also dedicated to the individual patient, template for spacers in concrete antibiotic, production of external ortheses and braces. The proper interaction between the orthopedic surgeon and the engineer is the basis of the success of the custommade product; once reached an agreement, about 30 days are required to receive the product. Conclusion. 3D printing technology is now considered a valuable weapon for solving difficult cases in the hands of an orthopedists. The most important limits consist of the risk of infection and osteointegration. Other indications will probably be found with the further development of techniques and materials